R&D/Clinical Trials

>

Latest News

Updated Trial Results Support Tagrisso as Standard-of-Care for EGFR-Mutated Lung Cancer
Updated Trial Results Support Tagrisso as Standard-of-Care for EGFR-Mutated Lung Cancer

March 26th 2025

Results from multiple clinical trials showed that Tagrisso demonstrated survival benefits in EGFR-mutated non-small cell lung cancer, both as monotherapy and in combination therapies.

Stock.adobe.com
VolitonRx’s Cancer Test Could be Used to Detect 21 Different Cancers, Study Suggests

March 24th 2025

Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities
Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities

March 21st 2025

Phase III Trial Shows Novartis’ Gene Therapy Significantly Improves Spinal Muscular Atrophy Outcomes
Phase III Trial Shows Novartis’ Gene Therapy Significantly Improves Spinal Muscular Atrophy Outcomes

March 21st 2025

Phase III Trials Show Povorcitinib Significantly Improves Hidradenitis Suppurativa Outcomes
Phase III Trials Show Povorcitinib Significantly Improves Hidradenitis Suppurativa Outcomes

March 19th 2025

Video Interviews
Podcasts

More News